Skip To Main Content

Artikelen

Sort by

Filters

Resetten
  • Therapeutische gebieden

SINUS-24/SINUS-52 Demonstrated Reduced Need for Surgery and Oral Corticosteroids — Dupilumab Real-World Data Reinforces with 100% Reduction in the First Year of Treatment in Patients with Severe Uncontrolled CRSwNP

This Italian monocentric study (De Corso et al., 2022) evaluated the real-life effectiveness of dupilumab over the first year of treatment of severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) (N=57).2 The results from this real-life observational study reinforces the efficacy of dupilumab demonstrated in the SINUS-24 and SINUS-52 randomized clinical trials and both the study design and results are consistent with the approved SmPC.1,2,3

Unstoppable commitment to ASCVD care for over 10 years

Het belang van longfunctie bij ernstig astma – Een klinisch perspectief

Cycle of Recurrence: A Challenge in CRSwNP Patients

Chronic Rhinosinusitis with Nasal Polyps: The Interplay of Type 2 Inflammation and Smell Loss

Chronic Rhinosinusitis with Nasal Polyps: More Than Just Nasal Obstruction

PCSK9 inhibitor treatment and outcomes

Loss of Smell in CRSwNP

Loss of sense of smell is a common symptom of chronic rhinosinusitis with nasal polyps (CRSwNP), but its impact is often underestimated. Learn how olfactory dysfunction affects patient’s quality of life and explore the underlying mechanisms driving smell loss in CRSwNP.

Biomarkers bij Astma: Vroege Interventie met Precisiegeneeskunde

Beyfortus®▼ (nirsevimab): effectiviteit en impact op de volksgezondheid in de dagelijkse praktijk

Insulin-Related Weight Gain in Type 2 Diabetes: Practical Guidance

Reframing the Insulin Conversation: Helping People With Type 2 Diabetes to Embrace Life